Gates-backed Exicure wraps 2016 with its first major collaboration and a plan for the year ahead
Exicure has crossed a few key items off the to-do list that dominates the existence of every upstart biotech. And it’s wrapping up 2016 with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
